首页 > 最新文献

Future cardiology最新文献

英文 中文
Impact of right ventricular failure on the outcomes of acute inferior wall myocardial infarction. 右心室衰竭对急性下壁心肌梗死预后的影响。
IF 1.6 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-01-01 Epub Date: 2024-07-23 DOI: 10.1080/14796678.2024.2378628
Rishi Shrivastav, Aaqib Malik, Adrija Hajra, Akshay Goel, Avilash Mandal, Sabyasachi Mukhopadhyay, Devesh Rai, Dhrubajyoti Bandyopadhyay

Aim: Right ventricular failure (RVF) complicates 30-50% of cases with inferior wall myocardial infarctions (IWMI). Large-scale studies exploring the recent trends in morbidity and mortality of IWMI with RVF in the context of improved reperfusion strategies are currently lacking.Materials & methods: The International Classification of Diseases, Tenth Revision, Clinical Modification codes were used to query the National Inpatient Sample of 2018-2019 to yield IWMI admissions and stratified based on presence of RVF. The primary outcome was in-hospital mortality.Results: Out of the 182,485 weighed hospital admissions for IWMI, 1005 patients (0.6%) also had RVF. Patients with both IWMI and RVF had significantly higher mortality than patients with IWMI and no RVF (p < 0.001).Conclusion: RVF in patients with IWMI is an independent predictor of poor outcomes.

目的:30%-50%的下壁心肌梗死(IWMI)患者会并发右心室功能衰竭(RVF)。目前还缺乏大规模的研究,探讨在改进再灌注策略的背景下,下壁心肌梗死并发右心室功能衰竭的发病率和死亡率的最新趋势。材料与方法:使用《国际疾病分类》第十版临床修改代码查询 2018-2019 年全国住院患者样本,得出 IWMI 入院情况,并根据是否存在 RVF 进行分层。主要结果是院内死亡率。结果:在182485名因IWMI入院的称重患者中,有1005名患者(0.6%)同时患有RVF。同时患有 IWMI 和 RVF 的患者的死亡率明显高于同时患有 IWMI 但没有 RVF 的患者(P 结论:IWMI 和 RVF 患者的死亡率均高于 IWMI 患者:IWMI 患者的 RVF 是不良预后的独立预测因素。
{"title":"Impact of right ventricular failure on the outcomes of acute inferior wall myocardial infarction.","authors":"Rishi Shrivastav, Aaqib Malik, Adrija Hajra, Akshay Goel, Avilash Mandal, Sabyasachi Mukhopadhyay, Devesh Rai, Dhrubajyoti Bandyopadhyay","doi":"10.1080/14796678.2024.2378628","DOIUrl":"10.1080/14796678.2024.2378628","url":null,"abstract":"<p><p><b>Aim:</b> Right ventricular failure (RVF) complicates 30-50% of cases with inferior wall myocardial infarctions (IWMI). Large-scale studies exploring the recent trends in morbidity and mortality of IWMI with RVF in the context of improved reperfusion strategies are currently lacking.<b>Materials & methods:</b> The International Classification of Diseases, Tenth Revision, Clinical Modification codes were used to query the National Inpatient Sample of 2018-2019 to yield IWMI admissions and stratified based on presence of RVF. The primary outcome was in-hospital mortality.<b>Results:</b> Out of the 182,485 weighed hospital admissions for IWMI, 1005 patients (0.6%) also had RVF. Patients with both IWMI and RVF had significantly higher mortality than patients with IWMI and no RVF (<i>p</i> < 0.001).<b>Conclusion:</b> RVF in patients with IWMI is an independent predictor of poor outcomes.</p>","PeriodicalId":12589,"journal":{"name":"Future cardiology","volume":" ","pages":"563-569"},"PeriodicalIF":1.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11486014/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141747920","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Electrocardiographic and biochemical predictors of left ventricular remodeling early after ST-segment elevation myocardial infarction. ST 段抬高型心肌梗死后早期左心室重塑的心电图和生化预测因素
IF 1.6 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-01-01 Epub Date: 2024-11-20 DOI: 10.1080/14796678.2024.2424128
Mert Doğan, Uğur Canpolat, Kudret Aytemir

Aim: We aimed to assess low to mid-range left ventricular ejection fraction (LVEF) predictors at one-month follow-up in STEMI patients using baseline electrocardiography (ECG) and standard laboratory tests.Methods: In this retrospective cross-sectional study, 130 STEMI patients (79% male, mean age: 57.2 ± 11.9 years) were enrolled. Multivariate linear regression analysis determined the relationship of baseline 12-lead ECG and clinical/laboratory parameters with LVEF at the 1st-month follow-up visit.Results: The mean LVEF of the patients at the 1st-month follow-up visit was 51.8 ± 8.7%. There was a significant negative correlation between age (r = -0.206)*, peak CK-MB level (-0.0411)**, QTc interval (r = -0.209)*, STE amount (mV) (r = -0.286)**, V5-6 RWPT (r = -0.238)** and aVR RWPT (r = -0.466)** with LVEF (*p < 0.05; **p < 0.01). The aVR R wave peak time (RWPT) (OR: 0.88, p < 0.01) and peak CK-MB level (OR: 0.91, p < 0.01) were the two most important predictors of low-to-mid-range LVEF (<%50) during mean 38 ± 5 days follow-up after STEMI.Conclusion: Our study results suggested that the baseline aVR RWPT and peak CK-MB level were associated with low-to-mid-range LVEF at the 1st-month follow-up after STEMI. These parameters may be used in the risk stratification of STEMI patients to develop LV remodeling during follow-up.

目的:我们旨在利用基线心电图(ECG)和标准实验室检查评估 STEMI 患者随访一个月时左心室射血分数(LVEF)的中低端预测指标:在这项回顾性横断面研究中,共纳入了 130 名 STEMI 患者(79% 为男性,平均年龄为 57.2 ± 11.9 岁)。多变量线性回归分析确定了基线12导联心电图和临床/实验室参数与第一个月随访时LVEF的关系:随访一个月时,患者的平均 LVEF 为 51.8 ± 8.7%。年龄(r = -0.206)*、CK-MB峰值水平(-0.0411)**、QTc间期(r = -0.209)*、STE量(mV)(r = -0.286)**、V5-6 RWPT(r = -0.238)**和aVR RWPT(r = -0.466)**与LVEF之间存在明显的负相关(*p p p p 结论:我们的研究结果表明,患者的基线LVEF与CK-MB峰值水平之间存在明显的负相关:我们的研究结果表明,基线 aVR RWPT 和 CK-MB 峰值水平与 STEMI 后 1 个月随访时低至中等 LVEF 相关。这些参数可用于 STEMI 患者在随访期间发生左心室重构的风险分层。
{"title":"Electrocardiographic and biochemical predictors of left ventricular remodeling early after ST-segment elevation myocardial infarction.","authors":"Mert Doğan, Uğur Canpolat, Kudret Aytemir","doi":"10.1080/14796678.2024.2424128","DOIUrl":"10.1080/14796678.2024.2424128","url":null,"abstract":"<p><p><b>Aim:</b> We aimed to assess low to mid-range left ventricular ejection fraction (LVEF) predictors at one-month follow-up in STEMI patients using baseline electrocardiography (ECG) and standard laboratory tests.<b>Methods:</b> In this retrospective cross-sectional study, 130 STEMI patients (79% male, mean age: 57.2 ± 11.9 years) were enrolled. Multivariate linear regression analysis determined the relationship of baseline 12-lead ECG and clinical/laboratory parameters with LVEF at the 1st-month follow-up visit.<b>Results:</b> The mean LVEF of the patients at the 1st-month follow-up visit was 51.8 ± 8.7%. There was a significant negative correlation between age (r = -0.206)*, peak CK-MB level (-0.0411)**, QTc interval (r = -0.209)*, STE amount (mV) (r = -0.286)**, V<sub>5-6</sub> RWPT (r = -0.238)** and aVR RWPT (r = -0.466)** with LVEF (*<i>p</i> < 0.05; **<i>p</i> < 0.01). The aVR R wave peak time (RWPT) (OR: 0.88, <i>p</i> < 0.01) and peak CK-MB level (OR: 0.91, <i>p</i> < 0.01) were the two most important predictors of low-to-mid-range LVEF (<%50) during mean 38 ± 5 days follow-up after STEMI.<b>Conclusion:</b> Our study results suggested that the baseline aVR RWPT and peak CK-MB level were associated with low-to-mid-range LVEF at the 1st-month follow-up after STEMI. These parameters may be used in the risk stratification of STEMI patients to develop LV remodeling during follow-up.</p>","PeriodicalId":12589,"journal":{"name":"Future cardiology","volume":" ","pages":"747-754"},"PeriodicalIF":1.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11622765/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142675287","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Successful nonsurgical therapeutic management in a case of early mechanical aortic prosthetic thrombosis and coronary embolism after a modified Bentall procedure. 一例改良 Bentall 手术后早期机械主动脉假体血栓形成和冠状动脉栓塞的成功非手术疗法。
IF 1.6 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-01-01 Epub Date: 2024-10-03 DOI: 10.1080/14796678.2024.2404332
Isabel Durães Campos, Ana Rita Ferreira, Armando Abreu, Sérgio Gaião

Prosthetic valve thrombosis, although rare, is a life-threatening complication of valve replacement surgery. The authors present an atypical case of a modified Bentall procedure with the CarboSeal Valsalva™ conduit complicated by an early mechanical prosthetic aortic valve thrombosis and coronary embolism. The patient was successfully treated with an emergency percutaneous coronary angioplasty and intracoronary thrombus aspiration of the left anterior descending artery, followed by a systemic 10 mg bolus of tissue plasminogen activator followed by ultraslow (25 h) infusion of low-dose (25 mg), while supported with venoarterial extracorporeal membrane oxygenation.

人工瓣膜血栓虽然罕见,但却是瓣膜置换手术中威胁生命的并发症。作者介绍了一例使用 CarboSeal Valsalva™ 导管的改良 Bentall 手术并发早期机械人工主动脉瓣血栓和冠状动脉栓塞的非典型病例。患者接受了急诊经皮冠状动脉成形术和左前降支动脉冠状动脉内血栓抽吸术,随后全身注射 10 毫克组织纤溶酶原激活剂,接着超慢速(25 小时)输注低剂量(25 毫克)组织纤溶酶原激活剂,并接受静脉体外膜肺氧合支持,治疗获得成功。
{"title":"Successful nonsurgical therapeutic management in a case of early mechanical aortic prosthetic thrombosis and coronary embolism after a modified Bentall procedure.","authors":"Isabel Durães Campos, Ana Rita Ferreira, Armando Abreu, Sérgio Gaião","doi":"10.1080/14796678.2024.2404332","DOIUrl":"10.1080/14796678.2024.2404332","url":null,"abstract":"<p><p>Prosthetic valve thrombosis, although rare, is a life-threatening complication of valve replacement surgery. The authors present an atypical case of a modified Bentall procedure with the CarboSeal Valsalva™ conduit complicated by an early mechanical prosthetic aortic valve thrombosis and coronary embolism. The patient was successfully treated with an emergency percutaneous coronary angioplasty and intracoronary thrombus aspiration of the left anterior descending artery, followed by a systemic 10 mg bolus of tissue plasminogen activator followed by ultraslow (25 h) infusion of low-dose (25 mg), while supported with venoarterial extracorporeal membrane oxygenation.</p>","PeriodicalId":12589,"journal":{"name":"Future cardiology","volume":" ","pages":"685-688"},"PeriodicalIF":1.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11552474/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142371566","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of complete versus culprit-only revascularization on major adverse cardiovascular event in diverse subpopulations. 在不同亚人群中,完全血运重建与单纯罪魁祸首血运重建对主要不良心血管事件的影响。
IF 1.6 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-01-01 Epub Date: 2024-09-04 DOI: 10.1080/14796678.2024.2387516
Huzaifa Ul Haq Ansari, Farea Noman Dar, Narmeen Shaikh, Ayesha Noman, Kamran Ahmed, Uzair Asad, Khansa Khalid, Moiz Ahmed, Ahmad Zakarya, Usman Leel, Ruhina Adil Shaikh, Kiran Abbas

Background: Myocardial infarction management relies on pharmaceuticals and interventions like percutaneous coronary intervention (PCI). While complete PCI has shown noninferiority to culprit-only PCI, its impact on major adverse cardiovascular events (MACE) outcomes in multiple subpopulations has been unknown.Methods: A systematic literature search (from January 2000 to May 2024) identified four relevant randomized controlled trials involving ST-segment elevation myocardial infarction patients. Data analysis employed a random-effects model with inverse variance weighting.Results: MACE risk was significantly lower in males than females undergoing complete PCI compared with culprit-only PCI (hazard ratio: 0.52; 95% CI: 0.39-0.68; p < 0.01; I2 = 53%). Furthermore, complete PCI significantly lowered the risk of MACE outcomes in patients without diabetes and in patients under the 65-year age limit in comparison to culprit-only PCI.Conclusion: Complete PCI reduces MACE risk in male, nondiabetic ST-segment elevation myocardial infarction patients under 65 with multivessel coronary artery disease, necessitating further investigation into outcome differences among different subpopulations.

背景:心肌梗死的治疗依赖于药物和经皮冠状动脉介入治疗(PCI)等干预措施。虽然完全 PCI 显示出非劣于单纯罪魁祸首 PCI,但其对多个亚人群的主要不良心血管事件(MACE)结果的影响尚不清楚:系统性文献检索(2000 年 1 月至 2024 年 5 月)确定了四项涉及 ST 段抬高型心肌梗死患者的相关随机对照试验。数据分析采用了反方差加权随机效应模型:结果:与单纯罪魁祸首PCI相比,男性接受完全PCI的MACE风险明显低于女性(危险比:0.52;95% CI:0.39-0.68;P 结论:完全PCI降低了男性心肌梗死患者的MACE风险:完全PCI可降低65岁以下男性非糖尿病ST段抬高型心肌梗死患者多支血管冠状动脉疾病的MACE风险,因此有必要进一步研究不同亚人群之间的结果差异。
{"title":"Impact of complete versus culprit-only revascularization on major adverse cardiovascular event in diverse subpopulations.","authors":"Huzaifa Ul Haq Ansari, Farea Noman Dar, Narmeen Shaikh, Ayesha Noman, Kamran Ahmed, Uzair Asad, Khansa Khalid, Moiz Ahmed, Ahmad Zakarya, Usman Leel, Ruhina Adil Shaikh, Kiran Abbas","doi":"10.1080/14796678.2024.2387516","DOIUrl":"10.1080/14796678.2024.2387516","url":null,"abstract":"<p><p><b>Background:</b> Myocardial infarction management relies on pharmaceuticals and interventions like percutaneous coronary intervention (PCI). While complete PCI has shown noninferiority to culprit-only PCI, its impact on major adverse cardiovascular events (MACE) outcomes in multiple subpopulations has been unknown.<b>Methods:</b> A systematic literature search (from January 2000 to May 2024) identified four relevant randomized controlled trials involving ST-segment elevation myocardial infarction patients. Data analysis employed a random-effects model with inverse variance weighting.<b>Results:</b> MACE risk was significantly lower in males than females undergoing complete PCI compared with culprit-only PCI (hazard ratio: 0.52; 95% CI: 0.39-0.68; <i>p</i> < 0.01; I2 = 53%). Furthermore, complete PCI significantly lowered the risk of MACE outcomes in patients without diabetes and in patients under the 65-year age limit in comparison to culprit-only PCI.<b>Conclusion:</b> Complete PCI reduces MACE risk in male, nondiabetic ST-segment elevation myocardial infarction patients under 65 with multivessel coronary artery disease, necessitating further investigation into outcome differences among different subpopulations.</p>","PeriodicalId":12589,"journal":{"name":"Future cardiology","volume":" ","pages":"627-637"},"PeriodicalIF":1.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11520548/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142125404","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Improvement of myocardial contractility with leadless endocardial single-lead atrial sensing ventricular pacing in patients with prolonged PQ interval. 通过无导联心内膜单导联心房传感心室起搏改善 PQ 间期延长患者的心肌收缩力
IF 1.7 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-01-01 Epub Date: 2024-01-15 DOI: 10.2217/fca-2023-0112
Andrea Igoren Guaricci, Vincenzo Ezio Santobuono, Nicolò Soldato, Paolo Basile, Nicola Bozza, Maria Cristina Carella, Paola Siena, Cinzia Forleo, Gianluca Pontone, Marco Matteo Ciccone

Aim: Micra AV represents a leadless endocardial pacing system able to detect atrial contractions providing atrioventricular synchrony. A reduction of myocardial contractility may be detected in case of first-degree atrioventricular block (AVB). Materials & methods: In six patients with first-degree AVB (PQ interval ≥220 msec) was evaluated the left ventricle global longitudinal strain (LV GLS) by speckle tracking (ST) echocardiography during single-lead atrial sensing ventricular pacing (VDD) stimulation as compared with spontaneous rhythm (SR), 24-48 h after Micra AV implantation. Results: A statistically significant difference between the two modalities was observed (LV GLS during SR: -14.7% [interquartile range (IQR) 5.5], LV GLS during VDD pacing: -16.1% [IQR 5.2]; p value = 0.041). Conclusion: Our preliminary results suggest an improvement of myocardial contractility with VDD pacing as compared with SR.

目的:Micra AV 是一种无导联心内膜起搏系统,能够检测心房收缩,实现房室同步。在出现一级房室传导阻滞(AVB)时,可检测到心肌收缩力的减弱。材料和方法:对六名一级房室传导阻滞(PQ 间期≥220 毫秒)患者在 Micra AV 植入 24-48 小时后进行单导联心房传感心室起搏(VDD)刺激时,通过斑点追踪(ST)超声心动图评估左心室整体纵向应变(LV GLS),并与自发节律(SR)进行比较。结果:观察到两种模式之间存在统计学意义上的显著差异(SR 期间的左心室 GLS:-14.7% [四分位数间距 (IQR) 5.5],VDD 起搏期间的左心室 GLS:-16.1% [IQR 5.2];P 值 = 0.041)。结论我们的初步结果表明,与 SR 相比,VDD 起搏可改善心肌收缩力。
{"title":"Improvement of myocardial contractility with leadless endocardial single-lead atrial sensing ventricular pacing in patients with prolonged PQ interval.","authors":"Andrea Igoren Guaricci, Vincenzo Ezio Santobuono, Nicolò Soldato, Paolo Basile, Nicola Bozza, Maria Cristina Carella, Paola Siena, Cinzia Forleo, Gianluca Pontone, Marco Matteo Ciccone","doi":"10.2217/fca-2023-0112","DOIUrl":"10.2217/fca-2023-0112","url":null,"abstract":"<p><p><b>Aim:</b> Micra AV represents a leadless endocardial pacing system able to detect atrial contractions providing atrioventricular synchrony. A reduction of myocardial contractility may be detected in case of first-degree atrioventricular block (AVB). <b>Materials & methods:</b> In six patients with first-degree AVB (PQ interval ≥220 msec) was evaluated the left ventricle global longitudinal strain (LV GLS) by speckle tracking (ST) echocardiography during single-lead atrial sensing ventricular pacing (VDD) stimulation as compared with spontaneous rhythm (SR), 24-48 h after Micra AV implantation. <b>Results:</b> A statistically significant difference between the two modalities was observed (LV GLS during SR: -14.7% [interquartile range (IQR) 5.5], LV GLS during VDD pacing: -16.1% [IQR 5.2]; p value = 0.041). <b>Conclusion:</b> Our preliminary results suggest an improvement of myocardial contractility with VDD pacing as compared with SR.</p>","PeriodicalId":12589,"journal":{"name":"Future cardiology","volume":" ","pages":"21-25"},"PeriodicalIF":1.7,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139466419","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effects of ursolic acid on cardiometabolic risk factors: a systematic review and meta-analysis. 熊果酸对心脏代谢风险因素的影响:系统综述和荟萃分析。
IF 1.6 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-01-01 Epub Date: 2024-05-29 DOI: 10.1080/14796678.2024.2349476
Pegah Rafiee, Niloufar Rasaei, Mohammad Reza Amini, Reyhaneh Rabiee, Zahra Kalantar, Fatemeh Sheikhhossein, Mohammad Gholizadeh, Azita Hekmatdoost

Aim: Ursolic acid (UA) has an important biological role in the fight against fat accumulation, insulin resistance, obesity and inflammation. Therefore, in the current review and meta-analysis work, we investigate the effects of UA (dosage range is 50.94 to 450 mg/day) on cardiometabolic risk factors. Materials & methods: After searching the studies up to February 2023, six articles were included in the study. Results: The pooled effect size showed that UA supplementation didn't significantly change body weight, body mass index, waist circumference, body fat percentage, lean body mass, systolic blood pressure, diastolic blood pressure, fasting blood glucose, insulin, triglyceride and high-density lipoprotein compared with control groups. Conclusion: UA supplementation had no significant effect on the cardiometabolic risk factors in adults.

目的:熊果酸(UA)在对抗脂肪堆积、胰岛素抵抗、肥胖和炎症方面具有重要的生物学作用。因此,在目前的综述和荟萃分析工作中,我们研究了 UA(剂量范围为 50.94 至 450 毫克/天)对心脏代谢风险因素的影响。材料与方法:检索截至 2023 年 2 月的研究,共纳入 6 篇文章。研究结果汇总效应大小显示,与对照组相比,补充尿酸不会显著改变体重、体重指数、腰围、体脂率、瘦体重、收缩压、舒张压、空腹血糖、胰岛素、甘油三酯和高密度脂蛋白。结论是补充尿酸对成年人的心脏代谢风险因素没有明显影响。
{"title":"The effects of ursolic acid on cardiometabolic risk factors: a systematic review and meta-analysis.","authors":"Pegah Rafiee, Niloufar Rasaei, Mohammad Reza Amini, Reyhaneh Rabiee, Zahra Kalantar, Fatemeh Sheikhhossein, Mohammad Gholizadeh, Azita Hekmatdoost","doi":"10.1080/14796678.2024.2349476","DOIUrl":"10.1080/14796678.2024.2349476","url":null,"abstract":"<p><p><b>Aim:</b> Ursolic acid (UA) has an important biological role in the fight against fat accumulation, insulin resistance, obesity and inflammation. Therefore, in the current review and meta-analysis work, we investigate the effects of UA (dosage range is 50.94 to 450 mg/day) on cardiometabolic risk factors. <b>Materials & methods:</b> After searching the studies up to February 2023, six articles were included in the study. <b>Results:</b> The pooled effect size showed that UA supplementation didn't significantly change body weight, body mass index, waist circumference, body fat percentage, lean body mass, systolic blood pressure, diastolic blood pressure, fasting blood glucose, insulin, triglyceride and high-density lipoprotein compared with control groups. <b>Conclusion:</b> UA supplementation had no significant effect on the cardiometabolic risk factors in adults.</p>","PeriodicalId":12589,"journal":{"name":"Future cardiology","volume":"20 3","pages":"151-161"},"PeriodicalIF":1.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11216268/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141456289","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Drug-eluting stents from cardiology to pneumonology. 从心脏病学到肺病学的药物洗脱支架。
IF 1.6 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-01-01 Epub Date: 2024-07-02 DOI: 10.1080/14796678.2024.2368346
Paul Zarogoulidis, Haidong Huang, Lutz Freitag
{"title":"Drug-eluting stents from cardiology to pneumonology.","authors":"Paul Zarogoulidis, Haidong Huang, Lutz Freitag","doi":"10.1080/14796678.2024.2368346","DOIUrl":"10.1080/14796678.2024.2368346","url":null,"abstract":"","PeriodicalId":12589,"journal":{"name":"Future cardiology","volume":" ","pages":"335-337"},"PeriodicalIF":1.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11457726/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141491615","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Takotsubo cardiomyopathy associated with free wall rupture and ventricular septal defect: a case report. 伴有游离壁破裂和室间隔缺损的 Takotsubo 心肌病:一份病例报告。
IF 1.6 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-01-01 Epub Date: 2024-08-05 DOI: 10.1080/14796678.2024.2382541
Ali Fatehi Hassanabad, Toshiro Sembo, William T Kidd, Bryan Har

Takotsubo cardiomyopathy is a rare cardiac presentation. It can be associated with severe complications such as hemodynamically significant ventricular septal defect and cardiac free wall rupture. In cases of mechanical complications, surgical repair is often indicated. Despite best medical and surgical efforts, patients with Takotsubo cardiomyopathy and mechanical complications carry significant mortality risk. Herein, we present an unusual presentation of Takotsubo cardiomyopathy that was associated with a mechanical complication. Although the patient underwent a successful surgical repair, she passed away from multiorgan failure during the postoperative period.

塔克氏心肌病是一种罕见的心脏疾病。它可能伴有严重的并发症,如血流动力学意义上的室间隔缺损和心脏游离壁破裂。如果出现机械性并发症,通常需要进行手术修复。尽管采取了最佳的医疗和手术措施,但患有塔克次博心肌病和机械并发症的患者仍有很大的死亡风险。在此,我们介绍了一名表现不寻常且伴有机械并发症的 Takotsubo 心肌病患者。虽然患者成功接受了手术修复,但在术后因多器官功能衰竭而去世。
{"title":"Takotsubo cardiomyopathy associated with free wall rupture and ventricular septal defect: a case report.","authors":"Ali Fatehi Hassanabad, Toshiro Sembo, William T Kidd, Bryan Har","doi":"10.1080/14796678.2024.2382541","DOIUrl":"10.1080/14796678.2024.2382541","url":null,"abstract":"<p><p>Takotsubo cardiomyopathy is a rare cardiac presentation. It can be associated with severe complications such as hemodynamically significant ventricular septal defect and cardiac free wall rupture. In cases of mechanical complications, surgical repair is often indicated. Despite best medical and surgical efforts, patients with Takotsubo cardiomyopathy and mechanical complications carry significant mortality risk. Herein, we present an unusual presentation of Takotsubo cardiomyopathy that was associated with a mechanical complication. Although the patient underwent a successful surgical repair, she passed away from multiorgan failure during the postoperative period.</p>","PeriodicalId":12589,"journal":{"name":"Future cardiology","volume":" ","pages":"543-546"},"PeriodicalIF":1.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11485990/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141888940","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Spontaneous coronary artery dissection: a case series illustrating current challenges in diagnosis and treatment. 自发性冠状动脉夹层:说明当前诊断和治疗挑战的系列病例。
IF 1.6 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-01-01 Epub Date: 2024-06-07 DOI: 10.1080/14796678.2024.2355808
Zade Bihag, Haris Patail, Ali Ghani, Raymond G McKay, Jawad Haider, Asad Rizvi, Daniel Bruce Fram

Spontaneous coronary artery dissection (SCAD) has been increasingly recognized in recent years as an important cause of acute coronary syndrome, myocardial infarction, and sudden death, especially among young women. However, due to the lack of clinical trials on SCAD, evidence-based guidance on management is currently lacking. Presented are four case studies that illustrate the recent insights and challenges in SCAD diagnosis and treatment.

近年来,越来越多的人认识到自发性冠状动脉夹层(SCAD)是导致急性冠状动脉综合征、心肌梗死和猝死的重要原因,尤其是在年轻女性中。然而,由于缺乏有关 SCAD 的临床试验,目前尚缺乏以证据为基础的治疗指导。本文介绍了四个病例研究,以说明 SCAD 诊断和治疗方面的最新见解和挑战。
{"title":"Spontaneous coronary artery dissection: a case series illustrating current challenges in diagnosis and treatment.","authors":"Zade Bihag, Haris Patail, Ali Ghani, Raymond G McKay, Jawad Haider, Asad Rizvi, Daniel Bruce Fram","doi":"10.1080/14796678.2024.2355808","DOIUrl":"10.1080/14796678.2024.2355808","url":null,"abstract":"<p><p>Spontaneous coronary artery dissection (SCAD) has been increasingly recognized in recent years as an important cause of acute coronary syndrome, myocardial infarction, and sudden death, especially among young women. However, due to the lack of clinical trials on SCAD, evidence-based guidance on management is currently lacking. Presented are four case studies that illustrate the recent insights and challenges in SCAD diagnosis and treatment.</p>","PeriodicalId":12589,"journal":{"name":"Future cardiology","volume":" ","pages":"369-376"},"PeriodicalIF":1.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11457618/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141901427","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ticagrelor monotherapy after acute coronary syndrome: lessons from the ULTIMATE-DAPT trial. 急性冠状动脉综合征后的替卡格雷单药治疗:ULTIMATE-DAPT 试验的启示。
IF 1.6 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-01-01 Epub Date: 2024-08-12 DOI: 10.1080/14796678.2024.2388472
Felice Gragnano, Vincenzo De Sio, Arturo Cesaro, Paolo Calabrò
{"title":"Ticagrelor monotherapy after acute coronary syndrome: lessons from the ULTIMATE-DAPT trial.","authors":"Felice Gragnano, Vincenzo De Sio, Arturo Cesaro, Paolo Calabrò","doi":"10.1080/14796678.2024.2388472","DOIUrl":"10.1080/14796678.2024.2388472","url":null,"abstract":"","PeriodicalId":12589,"journal":{"name":"Future cardiology","volume":" ","pages":"591-593"},"PeriodicalIF":1.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11520563/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141916545","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Future cardiology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1